PDL BioPharma Inc (PDLI)

3.56
NASDAQ : Health Care
Prev Close 3.56
Day Low/High 0.00 / 0.00
52 Wk Low/High 2.58 / 6.05
Avg Volume 1.29M
Exchange NASDAQ
Shares Outstanding 165.11M
Market Cap 589.46M
EPS 2.00
P/E Ratio 1.91
Div & Yield 0.20 (5.60%)

Latest News

First Week of PDLI February 2017 Options Trading

First Week of PDLI February 2017 Options Trading

Investors in PDL BioPharma Inc saw new options become available this week, for the February 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

This Stock Has A 5.79% Yield, Sells For Less Than Book, and Insiders Have Been Buying

This Stock Has A 5.79% Yield, Sells For Less Than Book, and Insiders Have Been Buying

In this series, we look through the most recent Dividend Channel ''DividendRank'' report, and then we cherry pick only those companies that have experienced insider buying within the past six months. The officers and directors of a company tend to have a unique insider's view of the business, and presumably the only reason an insider would choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both.

PDL BioPharma (PDLI): Today's Weak On High Volume Stock

PDL BioPharma (PDLI): Today's Weak On High Volume Stock

Trade-Ideas LLC identified PDL BioPharma (PDLI) as a weak on high relative volume candidate

PDL BioPharma About To Put More Money In Your Pocket (PDLI)

PDL BioPharma About To Put More Money In Your Pocket (PDLI)

Looking at the universe of stocks we cover at Dividend Channel, on 6/2/16, PDL BioPharma Inc will trade ex-dividend, for its quarterly dividend of $0.05, payable on 6/13/16. As a percentage of PDLI's recent stock price of $3.36, this dividend works out to approximately 1.49%, so look for shares of PDL BioPharma Inc to trade 1.49% lower — all else being equal — when PDLI shares open for trading on 6/2/16.

3 Small Biotechs That Look Very Healthy

Peter Lynch and other market legends would love these names.

Insiders Bullish on Certain Holdings of DES

Insiders Bullish on Certain Holdings of DES

A look at the weighted underlying holdings of the WisdomTree SmallCap Dividend Fund (DES) shows an impressive 17.3% of holdings on a weighted basis have experienced insider buying within the past six months. START SLIDESHOW:10 ETFs With Stocks That Insiders Are Buying » PDL BioPharma Inc , which makes up 0.49% of the WisdomTree SmallCap Dividend Fund (DES), has seen 2 directors and officers purchase shares in the past six months, according to the recent Form 4 data.

Commit To Purchase PDL BioPharma At $3, Earn 17.2% Annualized Using Options

Commit To Purchase PDL BioPharma At $3, Earn 17.2% Annualized Using Options

Investors considering a purchase of PDL BioPharma Inc shares, but tentative about paying the going market price of $3.73/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $3 strike, which has a bid at the time of this writing of 30 cents.

PDL BioPharma (PDLI) Strong On High Relative Volume Today

PDL BioPharma (PDLI) Strong On High Relative Volume Today

Trade-Ideas LLC identified PDL BioPharma (PDLI) as a strong on high relative volume candidate

PDL BioPharma (PDLI) Weak On High Volume

PDL BioPharma (PDLI) Weak On High Volume

Trade-Ideas LLC identified PDL BioPharma (PDLI) as a weak on high relative volume candidate

PDLI: Insiders vs. Shorts

PDLI: Insiders vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 02/12/2016 settlement date, and PDL BioPharma Inc is one of the most shorted stocks of the Russell 3000, based on 9.09 "days to cover" versus the median component at 5.27. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Ex-Dividends To Watch: 3 Stocks Going Ex-Dividend Tomorrow: PDLI, ALGT, AJG

Ex-Dividends To Watch: 3 Stocks Going Ex-Dividend Tomorrow: PDLI, ALGT, AJG

PDLI ALGT AJG are going ex-dividend tomorrow, Wednesday, March 02, 2016

PDL BioPharma About To Put More Money In Your Pocket (PDLI)

PDL BioPharma About To Put More Money In Your Pocket (PDLI)

Looking at the universe of stocks we cover at Dividend Channel, on 3/2/16, PDL BioPharma Inc will trade ex-dividend, for its quarterly dividend of $0.05, payable on 3/11/16. As a percentage of PDLI's recent stock price of $2.95, this dividend works out to approximately 1.69%, so look for shares of PDL BioPharma Inc to trade 1.69% lower — all else being equal — when PDLI shares open for trading on 3/2/16.

PDL BioPharma Inc Shares Slide 11.6% Below Garcia's Purchase Price

PDL BioPharma Inc Shares Slide 11.6% Below Garcia's Purchase Price

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on December 15, PDL BioPharma Inc's Vice President, CFO, Peter S.

4 Stocks That Increased Payouts This Week

A review of payout changes and upcoming must-own dates.

PDL BioPharma Announces 2016 First Quarter Dividend

PDL BioPharma Announces 2016 First Quarter Dividend

-- Company Shifts to Quarterly Assessment of Dividends to Capitalize on Long-Term Growth Opportunities --

PDL BioPharma Stock Sees Short Interest Decrease By 12.7%

PDL BioPharma Stock Sees Short Interest Decrease By 12.7%

The most recent short interest data has been released by the NASDAQ for the 01/15/2016 settlement date, which shows a 3,274,003 share decrease in total short interest for PDL BioPharma Inc , to 22,599,549, a decrease of 12.65% since 12/31/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Strong On High Volume: PDL BioPharma (PDLI)

Strong On High Volume: PDL BioPharma (PDLI)

Trade-Ideas LLC identified PDL BioPharma (PDLI) as a strong on high relative volume candidate

Commit To Purchase PDL BioPharma At $2, Earn 22.6% Annualized Using Options

Commit To Purchase PDL BioPharma At $2, Earn 22.6% Annualized Using Options

Investors eyeing a purchase of PDL BioPharma Inc stock, but cautious about paying the going market price of $2.87/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the May put at the $2 strike, which has a bid at the time of this writing of 15 cents.